Effect of selenium supplementation on lipid profile in hemodialysis patients


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
علوم پزشکی کرمانشاه
علوم پزشکی کرمانشاه

نویسندگان: یحیی پاسدارخشکناب , افشین الماسی , کامبیز جاسمی , حمیدرضا عمرانی , سیما گل محمدی

کلمات کلیدی: chronic kidney disease,Hemodialysis,Selenium,Lipid,End stage renal disease

نشریه: J Renal Inj Prev , 4 , 5 ,

اطلاعات کلی مقاله
hide/show

کد مقاله 9226
عنوان فارسی مقاله
عنوان لاتین مقاله Effect of selenium supplementation on lipid profile in hemodialysis patients
نوع مقاله مقاله اصیل (پژوهشی، Original)
بالاترین نمایه نامه بین‌المللی pubmed
سطح مقاله
IF
عنوان نشریه J Renal Inj Prev
نوع نشریه داخلی ایندکس شده
شماره نشریه 4
دوره 5
تاریخ انتشار شمسی 1395/07/10
تاریخ انتشار میلادی
آدرس لینک مقاله/ همایش در شبکه اینترنت http://journalrip.com/Archive/5/4
DOI 10.15171/jrip.2016.38
آدرس علمی (Affiliation) نویسنده متقاضی Nephrology and Urology Research Center,Kermanshah University Of Medical Sciences,Kermanshah,Iran

خلاصه مقاله
hide/show

Introduction: One of the major causes of mortality in chronic kidney disease (CKD) patients on hemodialysis is premature atherosclerosis. Selenium, a trace element involved in important enzymatic activities inside the body, has protective effects against lipid oxidation and inhibits cholesterol accumulation in blood vessels. Objectives: To determine the effect of selenium supplementation on lipid profile in hemodialysis patients. Patients and Methods: In this double-blinded randomized clinical trial which lasted for 3 months, 84 hemodialysis patients with selenium deficiency were divided into experimental group (received selenium supplementation) or control group (received placebo). Total cholesterol, low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), blood urea nitrogen (BUN), creatinine, and selenium level were measured before and after the study. Results: Mean (±SD) serum LDL-C level significantly increased in experimental group from 85.66 (±31.12) to 109.12 (±32.29) mg/dl (P < 0.001). Likewise, in control group serum LDL-C significantly increased from 80.55 (±21.13) to 97.05 (±28.07) mg/dl (P < 0.001). However, with control of LDL-C effect before and after the study, it was revealed that LDL-C change was not statistically significant (P = 0.21). Similarly, total cholesterol and triglyceride levels did not show significant changes before and after the study in any group. Conclusion: Selenium supplementation had no beneficial effect on lipid profile in hemodialysis patients

نویسندگان
hide/show

نویسنده نفر چندم مقاله نویسنده مسئول
یحیی پاسدارخشکنابسومخير
افشین الماسیپنجمخير
کامبیز جاسمیچهارمخير
حمیدرضا عمرانیاولخير
سیما گل محمدیدومبلي

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
JRIP-5-179.pdf1395/08/08376876دانلود